COO
The Cooper Companies, Inc. (S&P 500)
Healthcare — Medical Instruments & Supplies
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Price History
Fundamentals
| Market Cap | $14.05B |
| P/E Ratio (TTM) | 61.07 |
| Forward P/E | 14.42 |
| EPS (TTM) | $1.18 |
| Dividend Yield | - |
| Profit Margin | 5.57% |
| Revenue Growth | 7.90% |
| ROE | 2.85% |
| Debt/Equity | 33.09 |
| Recommendation | Buy 1.9 |
| Analyst Target | $81.21 |
| Analysts | 14 |
| Indexes | S&P 500 |
Technical Indicators
| RSI (14) | 58.5 |
| Beta | 0.84 |
| SMA 20 | $71.25 |
| SMA 40 | $68.81 |
| 52-Week High | $89.83 |
| 52-Week Low | $58.89 |
| 50-Day Avg | $67.10 |
| 200-Day Avg | $73.02 |
| Avg Volume | $2.91M |
| Volume | $1.77M |
Performance Analysis
BULLISHCOO shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 28, 2026 21:00 UTC
Back to Screener Export Report